GLA
SGMO

Great Lakes Advisors’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Great Lakes Advisors’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-523,194
Closed -$3.04M – 742
2022
Q1 		$3.04M Sell
523,194
-129,493
-20% -$770K 0.05% 329
2021
Q4 		$4.89M Sell
652,687
-14,533
-2% -$126K 0.07% 268
2021
Q3 		$6.01M Sell
667,220
-24,756
-4% -$245K 0.09% 242
2021
Q2 		$8.28M Sell
691,976
-2,694
-0.4% -$30.5K 0.13% 208
2021
Q1 		$8.7M Buy
694,670
+38,358
+6% +$517K 0.14% 202
2020
Q4 		$10.2M Sell
656,312
-347,413
-35% -$4.07M 0.19% 156
2020
Q3 		$9.48M Buy
1,003,725
+161,549
+19% +$1.75M 0.2% 146
2020
Q2 		$7.55M Buy
+842,176
New +$7.81M 0.18% 144

Other funds holding SGMO

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RCMU
Rokos Capital Management (UK) London, United Kingdom $13.2B AUM 85.71% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Great Lakes Advisors's SGMO Position: Q2 2022 in Review

Great Lakes Advisors sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2022, closing a stake of 523,194 shares — an estimated $3.04M sold.

Great Lakes Advisors first reported a position in SGMO in Q2 2020 and held it in 8 quarters. The position peaked at $10.2M in Q4 2020. 188 funds tracked by Wall St. Rank hold SGMO as of Q2 2022.

  • Great Lakes Advisors reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2022 after selling out during the quarter.
  • Great Lakes Advisors sold 523,194 SANGAMO THERAPEUTICS INC shares in Q2 2022, an estimated $3.04M.
  • Great Lakes Advisors first reported a position in SANGAMO THERAPEUTICS INC in Q2 2020 and held it in 8 quarters.
  • Great Lakes Advisors's SANGAMO THERAPEUTICS INC position peaked at $10.2M in Q4 2020.
  • 188 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2022.

Based on Great Lakes Advisors's 13F filing for Q2 2022, filed 9 Aug 2022.